0001801198-26-000014 | 6-K | XBRL Viewer

legn_CollaborationRevenue

298,400,000

Cost Of License And Other Revenue

legn_CollaborationRevenue

185,600,000

legn_CostOfLicenseAndOtherRevenue

500,000

Cost Of License And Other Revenue

legn_CostOfLicenseAndOtherRevenue

1,800,000

Selling And Distribution Expenses

legn_SellingAndDistributionExpenses

50,100,000

Selling And Distribution Expenses

legn_SellingAndDistributionExpenses

41,000,000.0

Collaboration Prepaid Leases

legn_CollaborationPrepaidLeases

35,000,000.0

Collaboration Prepaid Leases

legn_CollaborationPrepaidLeases

72,700,000

Time Deposits

legn_TimeDeposits

188,200,000

Time Deposits

legn_TimeDeposits

46,700,000

Other Payables And Accruals Current

legn_OtherPayablesAndAccrualsCurrent

130,200,000

Other Payables And Accruals Current

legn_OtherPayablesAndAccrualsCurrent

195,400,000

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

14,500,000

^[2]

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

(14,500,000)

^[2]

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

30,400,000

^[2]

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

(30,400,000)

^[2]

Increase Decrease Through Reclassification Of Vested Restricted Stock Equity

legn_IncreaseDecreaseThroughReclassificationOfVestedRestrictedStockEquity

Adjustments For Inventory Reserve Provision

legn_AdjustmentsForInventoryReserveProvision

(6,100,000)

Adjustments For Inventory Reserve Provision

legn_AdjustmentsForInventoryReserveProvision

(3,800,000)

Adjustments For Depreciation Of Right Of Use Assets

legn_AdjustmentsForDepreciationOfRightOfUseAssets

13,200,000

Adjustments For Depreciation Of Right Of Use Assets

legn_AdjustmentsForDepreciationOfRightOfUseAssets

2,800,000

Adjustments For Decrease Increase In Prepayments Other Receivable Other Assets

legn_AdjustmentsForDecreaseIncreaseInPrepaymentsOtherReceivableOtherAssets

(7,000,000.0)

Adjustments For Decrease Increase In Prepayments Other Receivable Other Assets

legn_AdjustmentsForDecreaseIncreaseInPrepaymentsOtherReceivableOtherAssets

(48,600,000)

Adjustments for Increase (Decrease) In Other Assets and liabilities, Net

legn_AdjustmentsForIncreaseDecreaseInOtherAssetsAndLiabilitiesNet

(2,000,000.0)

^[3]

Adjustments for Increase (Decrease) In Other Assets and liabilities, Net

legn_AdjustmentsForIncreaseDecreaseInOtherAssetsAndLiabilitiesNet

500,000

^[3]

Prepayment To Collaborator For Collaboration Right Of Use Assets

legn_PrepaymentToCollaboratorForCollaborationRightOfUseAssets

18,400,000

Prepayment To Collaborator For Collaboration Right Of Use Assets

legn_PrepaymentToCollaboratorForCollaborationRightOfUseAssets

15,400,000

Addition In Time Deposits

legn_AdditionInTimeDeposits

327,000,000.0

Addition In Time Deposits

legn_AdditionInTimeDeposits

100,000,000.0

Decrease In Time Deposits

legn_DecreaseInTimeDeposits

184,900,000

Decrease In Time Deposits

legn_DecreaseInTimeDeposits

374,000,000.0

Times Deposits Current And Noncurrent

legn_TimesDepositsCurrentAndNoncurrent

188,200,000

Times Deposits Current And Noncurrent

legn_TimesDepositsCurrentAndNoncurrent

563,700,000

Cash And Cash Equivalents As Stated In Statement Of Financial Position

legn_CashAndCashEquivalentsAsStatedInStatementOfFinancialPosition

646,400,000

Cash And Cash Equivalents As Stated In Statement Of Financial Position

legn_CashAndCashEquivalentsAsStatedInStatementOfFinancialPosition

441,700,000

Non-Cash Repayment Of Collaboration Interest-Bearing Advanced Funding

legn_NonCashRepaymentOfCollaborationInterestBearingAdvancedFunding

57,300,000

Non-Cash Repayment Of Collaboration Interest-Bearing Advanced Funding

legn_NonCashRepaymentOfCollaborationInterestBearingAdvancedFunding

$ 0

Disclosure of notes and other explanatory information [text block]

legn_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory

CORPORATE INFORMATION

Legend Biotech Corporation ("Legend"), was incorporated on May 27, 2015 as an exempted company in the Cayman Islands with limited liability under the Companies Act (As Revised) of the Cayman Islands. The registered office address of Legend is PO Box 10240, Harbour Place, 103 South Church Street, George Town, Grand Cayman KY1-1002, Cayman Islands.

Legend is an investment holding company. The Company's subsidiaries are principally engaged in the discovery, development, manufacturing and commercialization of novel cell therapies for oncology and other indications.

legn_RevenueFromLicensingOfIntellectualProperty

$ 5,100,000

legn_RevenueFromLicensingOfIntellectualProperty

9,300,000

legn_RevenueFromLicensingOfIntellectualProperty

1,600,000

Disclosure Of Timing Of Transfer Of Goods Or Services [Table Text Block]

legn_RevenueFromLicensingOfIntellectualProperty

$ 0

legn_DisclosureOfTimingOfTransferOfGoodsOrServicesTableTextBlock

An analysis of the timing of transfer of goods or services is as follows:


	Three months ended March 31,
(Dollars in millions)	2026		2025
Revenue at a point in time	$	300.0	$	185.7
Revenue over time*	5.1		9.3
Total Revenue	$	305.1	$	195.0

*All revenue streams are recognized at a point in time except for License Revenue for Novartis which is recognized over time.

Disclosure Of Detailed Information About Inventories Explanatory [Table Text Block]

legn_DisclosureOfDetailedInformationAboutInventoriesExplanatoryTableTextBlock


(Dollars in millions)	March 31, 2026		December 31, 2025
Raw materials	$	22.4	$	24.1
Work-in-process	5.2		1.1
Finished goods	9.5		6.8
Total collaboration inventories, net	$	37.1	$	32.0

Inventory reserve

legn_InventoryReserve

$ 12,500,000

Inventory reserve

legn_InventoryReserve

18,700,000

Interest Bearing Borrowings, Funding Advances

legn_InterestBearingBorrowingsFundingAdvances

250,000,000.0

Interest Bearing Borrowings Funded Interests Accrued

legn_InterestBearingBorrowingsFundedInterestsAccrued

73,300,000

Interest Bearing Borrowings, Funding Advances, Increase (Decrease)

legn_InterestBearingBorrowingsFundingAdvancesIncreaseDecrease

(57,300,000)

Interest Bearing Borrowings, Funding Advances, Net of Pre-Tax Profit Receivable

legn_InterestBearingBorrowingsFundingAdvancesNetOfPreTaxProfitReceivable

192,700,000

Authorized Share Capital

legn_AuthorizedShareCapital

200,000

Authorized Share Capital

legn_AuthorizedShareCapital

$ 200,000

Disclosure Of Movements In Company Share Capital And Share Premium Explanatory [Table Text Block]

legn_DisclosureOfMovementsInCompanyShareCapitalAndSharePremiumExplanatoryTableTextBlock

A summary of movements in the Company’s share capital and share premium is as follows:


(Dollars in millions, except share and per share data)	Number of shares in issue	Share capital		Share premium		Total
At December 31, 2025 and January 1, 2026	369,886,369	$	0.1	$	2,750.3	$	2,750.4
Exercise of share options	271,380	—		0.2		0.2
Reclassification of vesting of restricted share units	1,321,834	—		30.4		30.4
At March 31, 2026	371,479,583	$	0.1	$	2,780.9	$	2,781.0

Share Capital And Share Premium Number Of Shares In Issue

legn_ShareCapitalAndSharePremiumNumberOfSharesInIssue

369,886,369

Share Capital And Share Premium Number Of Shares In Issue

legn_ShareCapitalAndSharePremiumNumberOfSharesInIssue

371,479,583

legn_ShareCapitalAndSharePremium

$ 100,000

legn_ShareCapitalAndSharePremium

2,750,300,000

legn_ShareCapitalAndSharePremium

2,750,400,000

legn_ShareCapitalAndSharePremium

100,000

legn_ShareCapitalAndSharePremium

2,780,900,000

Exercise Of Share Option Number Of Shares In Issue

legn_ShareCapitalAndSharePremium

$ 2,781,000,000

legn_ExerciseOfShareOptionNumberOfSharesInIssue

271,380

Exercise Of Share Option

legn_ExerciseOfShareOption

$ 0

Exercise Of Share Option

legn_ExerciseOfShareOption

200,000

Exercise Of Share Option

legn_ExerciseOfShareOption

$ 200,000

Reclassification Of Vested Restricted Stock Units Number Of Shares In Issue

legn_ReclassificationOfVestedRestrictedStockUnitsNumberOfSharesInIssue

1,321,834

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

$ 0

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

30,400,000

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

$ 30,400,000

Number Of Countries To Receive Commerical Approval

legn_NumberOfCountriesToReceiveCommericalApproval

Forecast [Member]

Proceeds from Milestone Payments

legn_ProceedsFromMilestonePayments

$ 55,000,000.0

CHINA

Revenue From Licensing Of Intellectual Property and Other

legn_RevenueFromLicensingOfIntellectualPropertyAndOther

1,600,000

Revenue From Licensing Of Intellectual Property and Other

legn_RevenueFromLicensingOfIntellectualPropertyAndOther

100,000

Outside the United States of America [Member]

legn_CollaborationRevenue

82,000,000.0

Revenue From Licensing Of Intellectual Property and Other

legn_CollaborationRevenue

26,700,000

UNITED STATES

legn_RevenueFromLicensingOfIntellectualPropertyAndOther

5,100,000

Revenue From Licensing Of Intellectual Property and Other

legn_RevenueFromLicensingOfIntellectualPropertyAndOther

9,300,000

legn_CollaborationRevenue

216,400,000